Log in
Enquire now
‌

US Patent 7514069 Tumor-targeted optical contrast agents

Patent 7514069 was granted and assigned to Mallinckrodt (company) on April, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Mallinckrodt (company)
Mallinckrodt (company)
Date Filed
March 5, 2007
Date of Patent
April 7, 2009
Patent Application Number
11682032
Patent Citations Received
‌
US Patent 11872414 Methods of using ultrasound waves for sonodynamic therapy
0
‌
US Patent 11980777 Methods of producing randomized ultrasound waves for sonodynamic therapy
0
‌
US Patent 11975156 Methods of using planar or defocused acoustic waves for non-invasive sonodynamic therapy
0
‌
US Patent 11865372 Methods of treating tumors with drugs
0
‌
US Patent 11883242 System and method for scanning for a second object within a first object using an adaptive scheduler
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7514069
Patent Primary Examiner
‌
D. L. Jones

Find more entities like US Patent 7514069 Tumor-targeted optical contrast agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.